Why the study?
Managing ACS in patients with recent gastrointestinal bleeding presents a clinical dilemma balancing ischemic risk and life-threatening rebleeding, complicating the use of standard DAPT.
Population
An 80-year-old female with Klatskin tumor resection, recurrent GI bleeding, and severe anemia presenting with ACS
Design
Case report
Authors
Loading...
Optimal antiplatelet strategy after ACS with recent GI bleed remains uncertain; this Level 5 report leaves open need for prospective data.
This case highlights the extreme difficulty of managing STEMI in patients with severe anemia and recent GI bleeding, where conservative management may be necessary but carries a high risk of mechanical complications like VSD.
O'Rorke et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: